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The action of rifampicin on the RNA chain initiation catalysed by E, cali RNA polymeruse over dilkrent templates has been studied. The 
steady-state formation 01’ dinucleoside lctraphosphate under the condition of abortive initiation reaction was assayed. It was observed that 
rifampicin shows a spectrum of inhibitory cffecls on transcription initiation at different promoters. At LWO different promoters with a pyrimidinc 
nucleotide at the 5’.inithtion site, e.g. rr/tB P2 having CTP and iuc P2 having UTP. the effect of rifampicin on the abortive synthesis of the first 
phosphodiester bond was found to be total, even at low concentrations of the antibiotic. On the other hand, in most cases the efkt of rifampicin 
on the abortive synthesis with a purine nucluotide at the Y-initiation site was found to be only partial, with the exception f the T7A2 promoter, 
where rifampicin stimulotcs the abortive synthesis of pppGpC, It was also noticed that if there was a purine nuclcotide at the second position of 
a dinucleotide which had niready bczn synthesised by the enzyme, then further addition of the third nuclcolide was not blocked in the presence 
ofrifampicin. It appeared that a purine nucleotidc at the initiation site or at the product terminus ite of a translocated dinucleotide behaved similary 
towards rifampicin. In the same way, if this position was occupied by a pyrimidinc. rikmpicin would inhibit further phnsphodicsur synthesis, even 
ai n very low concentration. The stimulatory effect ol’rifampicin at the T7A2 promoter was presumably because here a ternary complex containing 
the promoter, enzyme and the abortive transcript pppGpC was initially stable. but dissociated upon addition of rif;lmpicin, resulting in the rapid 
turn-over of the product. 
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1. INTRODUCTION 
The rifampicin class of antibiotics have been exten- 
sively studied ever since the observation of Sippel and 
Hartmann that they inhibit the initiation of RNA syn- 
thesis in E. co/i [l]. A number of studies carried out in 
the past showed that RNA polymerase mutations con- 
ferring resistance to rifampicin are located exclusively 
in the ,B subunit [2-51. Since RNA polymerase from E. 
co/i is a large, multi-subunit enzyme (~&!?‘(T,M~, 
450,000), its nature of binding with rifampicin has been 
a matter of interest fcr sometime [6,7]. It appears that 
a proper juxtaposition of four segments of the/3 subunit 
is necessary for the creation of the rifampicin binding 
siie [5], which requires the assembly of core RNA 
polymerase (a&8’). This probably explains why the iso- 
lated ,8 subunit [S] and subassembly, a-J [9], show, re- 
spectively, no or little binding with rifampicin. 
On the mechanism of action of rif’ampicin, two exper- 
imental observations are noteworthy. Firstly, the major 
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effect of rifampicin was found to be a total block of the 
translocation step that would ordinarily follow the for- 
mation of the first phosphodiester bond [lo]. It has also 
been proposed that rifampicin destabilizes the ternary 
complex by interfering with the binding of the oligonu- 
cleotides to the active enzyme-DNA complex [I 11. 
However, Kessler and Hartmann [12] showed that ri- 
fampicin strongly stimulated dinucleotide synthesis at 
25°C and inhibited it, as expected, at 37°C. The reason 
behind this behaviour emains unexplained to date. It 
was also observed that the formation of pppApApC at 
the ilPR, promoter in the abortive initiation reaction was 
not inhibited by rifampicin [lo]. The question remains 
of whether the action of rifampicin on the transcription 
initiation is promoter dependent. Thus, despite xhaus- 
tive and generalised studies in this area there remain a 
number of points which need to be addressed. 
In the present study, we have tried to answer these 
questions by selectively studying the effect of rifampicin 
on transcription initiated at T7 early promoters which 
are known to be strongest in vim [13], as well as rRNA 
promoters. Availability of the promoters as separate 
transcription units cloned in pBR322 [14] greatly aided 
the use of these promoters as templates for the tran- 
scription reaction studied here. 
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2. MATERIALS AND METHODS 
2. I* il~lrrreriuis 
All the chemicals and bu&rs used in this study were of the purest 
grade available. The nuclcotidcs wcrc purchased irom Boehringcr and 
rifampicin from Sigma. Radionucleotides were obtained from Amcr- 
sham or Bhabha Atomic Research Centrc, India. 
For any kind of abortive initiation assay, it is essential to cheek the 
qualily of the triphosphatcs as well as to character& the product 
formed. All the triphosphates were routinely chromatographed on a 
polyethylene amine (PEI) plate against ammonium carbonale butI& 
[I51 and their identity confirmed under IJV light by either their RP 
value or by comparison with a known standard. 
E. cofi RNA polymcrasc was purified from mid-log phase cells of 
a RNase I‘ strain (MRE 600) following essentially the method of 
Burgess and Jcndrisak [I61 with a modification developed in this 
laboratory [I 71. The enzyme was found to have a specilic activity of 
2200 U/mg consisting of 60% active molecules. The enzyme purified 
in this way was routinely stored in 40 mM Tris-Cl (pH 7.9), 50% 
glycerol, 0.2 M KCI, IO mM M&Cl!, 0.2 M EDTA and 0.1 mM 
dithiothrcitol (DTT) at -2OOC. However, we also observed that this 
enzyme is very stable in its solid form upon lyophiliwtion. The E. co/i 
RNA polymerax was dialysed against a glycerol free buffer contuin- 
ing 10 mM Tris-Cl (pH 7.9). 0.1 mM EDTA and 0.2 mM DTT 
overnight prior to lyophilization. Subsequently the product was kept 
at 4OC and reconstituted when necessary with a buffer contitining IO 
mM Tris-CI (pH 7.9), 5% glycerol and 0.2 mM DTT. The protein 
concentration was determined by UV absorption using an extinction 
coclncicnt (I 8 cl ?110 ,,) of 6.2 [Is]. TIIC rifampicin concentration was 
fixed using the molar extinction coefficient 28,000 at 334 nm [l9]. 
Dcrivativcs oTE. c&strain HMS 174, each containing plasmid PAR 
1435 (T7Al), PAR 1539 (T7A2) or PAR 1354 (T7A3), were kindly 
provided by Dr. A.H. Rosenberg and Dr. F.W. Studier of Brookhaven 
National Laboratory, NY. Each of these plasmids has a sin.& T7 
early promoter as denoted in parenthesis [l4]. Plasmid DNA pKK 
3535 with the whole r,aB operon, containing both PI and P2 promos- 
cm, was akind gift from Dr. David Schlcssinger’s laboratory at Wash- 
ington Univcnity, St. Louis. pUC9 plasmid was used as a template 
when the synthesis of the abortive product over the /UC promoter was 
followed. 
2.2. Iu~lhOdS 
The plasmids were purified by the alkaline*lysis method, followed 
by CsCl gradient o isolate supercoiled DNA [30]. The promotcr- 
containing inserts in the GarrtHI site ofpBR322 were checked by the 
run-off transcription of S&-digested plasmid over 4% denaturing 
polyacrylamidc gel. In all cases ihc length of the transcript indicated 
that the initiation was laking place at the desired position. 11 should 
be mentioned at this point that the vector promoters are much weaker 
in comparison to the inserts containing T7 early promoters in vitro 
and therefore, ven in tbc presence of a molar excess of RNA polym- 
erase, transcription almost exclusively initiates at the inserts. In all the 
cases mentioned below plasmids linearized with C/u1 were used as 
templates. In the case of pKK3535, a OurrfHI-Hl/ldIII fragment con. 
taining both PI and P2 promoters were used as tcmplatc. Syntheses 
of the dinuclcoside tetraphosphatcs at different promoters were car- 
ricd out following the protocol described before [IO,211 for the abor- 
tive initiation reaction in the transcription buffer containing 40 mM 
Tris-Ci (pH 7.9). 5 mM MgCIz,50 mM KCI tmd 1 mM DTT. To ensure 
that the abortive transcripts were initiated at the correct position, we 
checked the abortive transcription with various combinations of nu- 
cleotidcsat thevectors alone, as well as those containing the promoter 
inserts, and the products of such reactions were analyscd in the follow- 
ing way: firstly, the &values of thediffcrcnt products were monitored 
and checked with standard values from litcraturc wherever available. 
The products of the abortive initiation assay were also confirmed by 
treating the di- or trinucleotides, as appropriate, with alkaline phos- 
phatasc and then co-migrating them over a PEI plate with commercial 
or synthetic oligonuc!cotides. The length of the transcripts was also 
checked by running them over a 15% polyacrylamide gel [22]. Gel 
mobility shift assay of the complex was carried out according to the 
method of Fried and Crolhers [23]. Urea-polyacrylamidc gel electro- 
phorusis of the abor:ivc transcription products were performed ssen- 
tially following the standard protocol and also with the help of a 
rcrcntly developed modilication [24]. 
3. RESULTS 
3.1. Rifirmpicitt-induced inhibirion of aborrive synrltesis 
During the course of our investigation with T7 early 
promoters, we obtained a clone of T7A2 promoter 
where the sequence inthe - 10 region was altered, result- 
ing in reduced strength of the promoter [25]. The order 
of the base was ‘TAGCGA’ instead of TAGAAT, and 
we named this promoter T7A2’. The initiation sequence 
under the control of T7A2’, however, remained unal- 
tered. 
Table i lists all the promoters that we studied here 
and the effect on them of rifampicin. The percentage of
inhibition was calculated from the changes in the total 
area of the peaks in the paper chromatograph corre- 
sponding to the oligonucleotides. It is now well accepted 
that rifampicin does not inhibit the formation of the 
first phosphodiester bond [lo], but interferes with the 
translocation event during the formation of the second 
phosphodiester bond. As expected, rifampicin did not 
show any appreciable ffect on the abortive synthesis at 
T7A I, or at T7A3 (Table I). However, at lac Pl even 
the formation of a trinucleotide product, pppGpApA, 
was only minimally abrogated by the antobiotic. Abor- 
tive synthesis at T7A2 showed enhanced accumulation 
of the product when rifampicin was added to the me- 
dium (Fig. la). AT T7A2’, the effect of rifampicin was 
found to be minimal (Table I). However, in both these 
cases as well as with poly (dG-dC), when the reaction 
was initiated with GDP instead of GTP, rifampicin 
showed a partial inhibitory effect on the abortive syn- 
thesis. It should be noted at this point that at the poly 
(dG-dC) template the use of GDP instead of GTP en- 
sured the synthesis of only the dinucleotide product, 
PPGPC. 
It should also be mentioned at this point that the 
abortive initiation assay at each of these promoters was 
carried out for different time-spans o that sufficient 
amounts of product were accumulated in each case and 
percent inhibition of dinucleotide synthesis in the pres- 
ence of rifampicin could be followed with sufficient 
ease. Under such assay conditions only the differential 
strength of these promoters is reflected. However, gel 
analysis and chromatographic runs ensured that no 
other products were formed other than those expected. 
Thus Table I lists a comparative study of the rifampicin- 
induced inhibition of the synthesis of the first few 
phosphodiesters under steady-state conditions. 
Surprisingly, it was observed that rifampicin, even at 
a concentration level as low as 12 ,uM, totally inhibited 
abortive synthesis both at the FFIIB P2 and luc P2 pro- 
moters (see Table 1 and Fig. 1). Both of these inhibitons 
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Fig. I. (R) Polyncrylamide gel (25%) clectrophoresis of the abortive transcripts in the presence and absence of rifampicin. Lanes 1 and 2 represent 
transcription over the template pARI (T7Al) in the absence and presence. respectively, of rifampicin (50,ugIml). The substrates were 800~M 
ATP and 6 @vl[ct-“‘P]-UTP (2 jfCi/nmol). Lanes 3 and 4 represent transcription over the template pARI (T7A2) in the absence and presence 
of rihmpicin. respectively. GTP was 800pM and [~L-~~P]-CTP was 6pM (2,KiInmol). The concentration of DNA was 0,4 mM DNA.phosphorus, 
and of RNA polymerase 0. IGpM. (b) A similar transcription reaction was carried out at :ne kc+ P2 promoter nsing UTP and [a-32P]-CTP following 
the same protocol as given in [24]. Lane I, without rifarnpicin; lane 2 with rifampicin (50 /.J &m/ml). 
were studied by paper chromatographic as well as gel Crothers [24]. In both cases, accumulation of a dinucle- 
electrophoretic analysis (Fig. lb). On examination of oeide was also not observed in the presence of ri- 
Table 1 it was revealed that both of these promoters fampicin, either by gel or by chromatographic separa- 
have a pyrimidine nucleotide at the 5’ initiation site. tion, indicating that rifampicin totally blocked even the 
Generally two abortive products were obtained at fuc frornation of the first phosphodiester bond. (At rrtd3 Pl, 
P2, UUC and UUCC (Fig. lb), upon the addition of [&?P]ATP was used as tracer instead of CTP to avoid 
UTP and CTP, as observed before by Gartenberg and signals from rrrzB P2,) 
Table 1 
Effect of rifampicin (60pM) on the abortive initiation of transcription at different promoters 
Promoter Initial transcribed 
sequence 
Nuclcotidcs provided in the Expected R,. value Percentage of inhibitionU 
abortive initiation reaction products 
T7AI 
T7A2 
T7A2 
T7A2’ 
T7A2’ 
poly d(G-C) 
T7A3 
rrd3 PI 
rrrrB P2 
kc PI 
kc P2 
AUCGAGAGGGACAC 
GCLJAGGTAACACTA 
GCUAGGTAACACTA 
GCUAGGTAACACTA 
GCUAGGTAACACTA 
GCGCGCGCGCGCGC 
AUGAAACGACAG 
ACUGACACGG 
CCCGCGCCGC 
GAAU UGTGAGC 
UUCCGGGCTCG 
ATP,[a-‘?P]UTP 
GTP,[r&‘]CTP 
GDP,[aJzP]CTP 
GTP,[a3zP]CTP 
GDP,[c&~~P]CTP 
GDP.[a-“zP]CTP 
ATP,[~z-~~P)UTP 
[@P]ATP, CTP 
[or-“‘P]CTP 
[a-“PIGTP, ATP 
[a-“P]CTP, UTP 
PPPAPU 0.44 
PPPGPC OS6 
PPGPC 0.4.9 
0.56 
;gY 0.49 
PPGPC 0.49 
PPPAPU 0.44 
PPPAPC 0.38 
PPPCPCPC 
PPPGPAPA - 
pppUpUpC and - 
PPPUPUPCPC 
40 
Nil (several-fold increase)s 
44 
0 (slight increase) 
58 
G5 
20 
0 
100’ 
7 
1OCr 
“This is an average value obtained from various chromatographic and elcctrophorrtic assays 
“No inhibition was observed with concentrations of rifampicin up to 240 PM 
‘Total inhibition was observed with concentrations of rifampicin as low as I2pM 
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Fig. 2. Gel mobility rcatardation and ternary complex analysis of pARI (T7A2) with RNA polymcrase und NT&. The control plasmid DNA 
(20 nM, lanes I nnd 7) W;IS treated nt 37% for IO min with E. coli RNA polymcrase (200 nM) in the absence of any NTP (lane 2). in the presence 
of (lane 3) GTP alone, (lane 4) GTP and CTP, (lane 5) GTP, CTP and UTP. and (lane 6) all four NTPs. Lanes 8-12 are the same as lanes 2-6. 
respectively, except hat these were incubated with l00pM rifampicin at 37°C for 5 min prior to locding. The concentration ofGTP was 2CtOyM. 
while the other NTPs were used at IO PM: [a-“PI-CTP was at 2 ,uCi/nmol. Samples were analyzed over a 1% agarose gel in Tris-borate-EDTA 
buffer (~1-1 8.3) at 1.5 V/cm for 6 h. Lanes 13-24 represent the same samples as lane I-1 2. rcspcctively. when dried and nutoradiographcd. 
Upon examination of Table I, two observations ap- 
pear to be noteworthy: (i) there is a diflerence between 
the purinc or pyrimidine at 5’ initiation site towards 
rifampicin-induced inhibition of abortive synthesis, and 
(ii) both T7A2 and T7A2’ show stimulation of abortive 
transcription in the presence of rifampicin. 
3.2. Srability of the transcripriotz cottzpies at T7A2 OI 
T7A2’ in the preserrce of rifampicit~ 
Schultz and Zillig [l l] reported earlier that rifampicin 
destabilises the ternary complex of DNA, enzyme and 
short transcripts. Such effects can best be seen at the 
promoters, where a stimulatory effect of rifampicin on 
abortive transcription was observed. Therefore, we de- 
cided to check the stability of the ternary transcription 
complex in the presence of rifampicin at the T7A2 pro- 
moter. When thu second nucleotide, CTP (see Table l), 
was kept radio-labelled, and the transcripiion was car- 
ried out over a &I-linear&d pla;mid, PAR 1539, that 
contains the T7A2 promoter, a stable ternary complex 
was formed upon the addition of the first two or three 
nucleotides, producing, respectively, pppGpC and 
pppGpCpU. This was confirmed by autoradiography 
where the retarded DNA-enzyme complex band was 
detected (Fig. 2). We did not try to quantitate the per- 
centage of the DNA-RNA polymerase complex that 
retained the short transcripts. However, these com- 
plexes were stable to heparin but dissociated completely 
in the presence of rifampicin, as observed by following 
the disappearance of radioactivity in the gel (see Fig. 2). 
Tl~us. it appears that rifampicin stimulated the turn- 
over of the abortive transcripts ynthesized at T7A2 by 
destabilizing the ternary transcription complex. 
DISCUSSlON 
If the differential inhibition by rifampicin of abortive 
initiation at different promoters could be explained in 
terms of a mechanism, then it should also reflect some 
aspects of the initiation of transcription. Analysis of the 
results in Table 1 indicate that there is a correlation 
between the differential effect of rifampicin and the na- 
ture of the abortive initiation products at the various 
promoters. When a pyrimidine nucleotide was occupy- 
ing the 5’ initiation site, as in the case of rrnB P2 or IBC 
P2, contrary to the observation made by McClure and 
Cech [IO], even the first phosphodiestcr synthesis was 
totally inhibited by rifampicin. As most of the RNA 
message in E. cob initiates either with A or G, this 
observation has eluded us for a long time. Interestingly, 
we obzerved that in the cases where the second nucleo- 
tide or the third nucleotide were also purines, ri- 
fampicin-induced inhibition of the second or third 
phosphodiester formation was minimal. It can be ex- 
pected that after the synthesis of the first 
phosphosdiester bond, the dinucleotide translocates in 
such a way that the second nucleotide of the r:ral?s!o- 
cated dimer occupies the position which was hitherto 
occupied by the first nucleotide. Thus the product ter- 
minus site is Ihe same as the initiation site before prod- 
uct forilration. From out results in Table I, we would 
like to propose that if there is a pyrimidinc nucleotide 
at the initiation site or product terminus ite, then the 
rifampicin effect would be total for the next phosphod- 
iester synthesis. On the other hand, if this site is occu- 
pied by a purine nucleotide, rifampicin-induced inhibi- 
tion for the next phosphodiester would be much less. It 
was noticed earlier [26] that the synthesis of UpApU 
from UpA and UTP over poly d(A-T) was only partially 
inhibited by rifampicin. 
The assumption that the rifampicin-bound RNA 
polymerase distinguishes the substrates at the initiation 
(or product terminus) site for its inhibitory efl%cts be- 
comes furlher evident when GDP is used instead of 
GTP in the abortive initiation reactions. Rifampicin 
exerted a partial inhibition on the synthesis of PpGpC 
with GDP and CTP as substrates at the T7A2 and 
T7A2’ promoters. as well as poly d(G-C). One plausible 
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explanation for all these results is that the binding of 
rifampicin to polymerase induces a conformational 
change in the enzyme such that the geometry of at least 
the initiation nucleotide binding site (product terminus 
site, so called after the first phosphodiester formation 
and translocation) is altered. Our earlier finding that 
rifampicin exerts its inhibitory effects by binding to a 
site on the enzyme 30 8, away [7] from the substrate 
binding site also supports this point. Normally the initi- 
ation nucleotide should hold the 3’ -OH of the bound 
nucleotide oriented appropriately for the nucleophilic 
attack on the NTP bound at the elongation uc!eotide 
site, resulting in phosphodiester formation. Thus, in the 
rifampicin-bound enzyme, the differential inhibition ob- 
tained with difrerent nucleotide substrates may be be- 
cause of their altered orientation in the binding site, 
with the pyrimidines fitting least well. 
The fact that a transcription complex at the T7A2 
promoter retains a dinucleotide transcript, pppGpC, 
explains the very low rate of abortive initiation at this 
promoter. The stability of this dinucleotide product in 
the complex is reduced by the binding of rifampicin to 
the enzyme, thus resulting in an enhanced rate of turn- 
over of the dinuclcotide. This also explains a lone obser- 
vation made earlier [12] that rifampicin activates abor- 
tive synthesis at 25°C. It is expected that the turn-over 
of the abortive product at this temperature is rate-limit- 
ing but is enhanced in the presence of rifampicin. 
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